Mature blood cells derive from primitive cells through a complex and poorly understood process that involves an interplay of transcription factors and epigenetic modifications. We now show that multiple human hematopoietic progenitor phenotypes display a common repressive H3K27me3 signature (R>0.97) together with their mature lymphoid, but not their differentiated monocyte and erythroid progeny. This signature includes many large organized H3K27me3 domains that we also show are required for the production of differentiating lymphoid cells. These results reveal H3K27me3 contraction to play a previously unknown intermediate step in differentially regulating the activation of terminal differentiation programs in normal human lymphoid and myeloid progenitors.
Introduction
Epigenetic modifications govern local chromatin activity and support gene activation or silencing through the regulation of chromatin structure and DNA accessibility 1, 2 . Numerous cell differentiation processes are known to be accompanied by obligatory changes in chromatin structure mediated by proteins that specifically modify histones and thereby establish and maintain defined transcriptional regulatory states [3] [4] [5] [6] [7] . However, the details of epigenomic programing changes that accompany lineage restriction, and if, and how regulatory changes may also occur during the activation and execution of terminal differentiation programs in normal tissues remain poorly defined.
Hematopoiesis describes the process through which multiple types of functionally required but short-lived, mature blood cells are produced, and therefore have to be continuously replaced lifelong 8 . A ready accessibility of the more primitive cells responsible for the output of mature blood cells has made this system an attractive one to analyze the dynamics of epigenome programming that underpins this process [9] [10] [11] [12] . A prevailing view posits that after birth, a population of self-renewing hematopoietic stem cells (HSCs) residing within a supportive bone marrow niche generate derivative progenitors with reduced proliferative capacity but variable lineage options that then undergo a lineage restriction step prior to activating the final lineage programs that allow the full spectrum of mature blood cell types to be produced 13, 14 . The process of lineage restriction is thought to involve the epigenetic demarcation of specific genomic regions that make them accessible to particular transcription factors which, in turn, ultimately activate lineage-specific gene expression programs. However, the molecular details of these steps are not well delineated.
Previous studies using chromatin immunoprecipitation sequencing (ChIP-seq) targeting sites of permissive histone modifications and transposase-accessible chromatin sequencing (ATAC-seq) have provided insight into the dynamics of active regulatory regions in the genomes of variously defined primitive subsets of mouse and human hematopoietic cells [9] [10] [11] . Together, these have suggested a model in which certain enhancers are initially "primed" during the earliest stages of hematopoietic cell differentiation by an acquisition of "permissive" histone 3 lysine 4 monomethylation (H3K4me1) modifications. Then later, these same histones gain additional H3K27ac histone modifications that enable terminal differentiation programs to become activated 9 .
However, a comprehensive analysis of the chromatin modifications that take place during the early stages of human hematopoiesis has remained uncharacterized.
To address this gap, we generated detailed genome-wide datasets and measured permissive and repressive histone modifications, DNA methylation and transcriptional states present in a series of phenotypically defined subsets of normal human cord blood (CB) cells. To identify changes associated with different stages in the differentiation process as currently inferred from functional assays 14, 15, 16 we focused on 8 phenotypically defined subsets that are selectively enriched in cells at different stages of hematopoietic differentiation. Four of these phenotypes identify cells with progenitor activity but distinct lineage options 16 . The other 4 represent different downstream mature or maturing blood cell types. All 8 populations were isolated by fluorescent activated cell sorting (FACS) from CB samples based on their differential expression of historically defined surface marker profiles. The 4 progenitor populations together constitute the bulk of the CD34 + CB population. They consisted of the CD38subset, which contains the most primitive cells and all HSCs and 3 phenotypically distinguished subsets of the CD38 + cells historically referred to as common myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs) and megakaryocyte-erythroid progenitors (MEPs). The 4 more differentiated cell types also present in the light-density fraction of CB cells were circulating erythroblasts (hereafter referred to here as "erythroid precursors"), monocytes, mature B cells and mature T cells.
Analysis of repressive chromatin states from these cell types revealed that all 4 of the progenitor populations share a nearly identical H3K27me3 signature (gene promoter Spearman correlation R>0.97) including large organized chromatin K27-modification (LOCKs) domains that were not present in the 2 distinct mature myeloid lineages analyzed (i.e., erythroid precursors and monocytes). In contrast, we found the mature lymphoid cells retained the K27 LOCKs common to all 4 progenitor subsets. Analysis of the enhancer landscape revealed that a majority of traditionally defined active enhancers found in differentiated cell types were already evident within the progenitor populations and those unique to differentiated cell types are found almost exclusively within the boundaries of super-enhancers. From these findings, we propose a model in which the chromatin configuration changes that contribute functionally to the normal process of human hematopoietic differentiation include both active and repressive histone modifications that occur after, as well as during, lineage restriction.
Results

Functionally distinct human hematopoietic progenitors share a common polycomb signature
We first undertook a comprehensive mapping of the epigenetic and transcriptional states of historically defined immunophenotypes of human CB cells using our low input ChIP-seq protocol 17, 18 to identify H3K4me3, H3K4me1, H3K27me3, H3K27ac, H3K36me3, and H3K9me3 sites genome-wide, plus whole genome bisulfite sequencing and RNA-seq protocols following IHEC standards 19 (Fig. 1a and S1a). A standardized analytical pipeline was then applied to qualify and analyze the resulting data (see methods).
RNA expression profiles among the progenitor populations analyzed (CD34+CD38-cells, CMPs, GMPs and MEPs) were more highly correlated (Spearman R >0.92) with each other than with any of the 4 more mature CB cell types examined; i.e., erythroid precursors, monocytes and B-and T- in MEPs were enriched in terms related to myeloid lineage differentiation (Benjamini q-value <10e-3) ( Fig. S2d) . Genes up-regulated in CD34+CD38-cells and CMPs as compared to the more differentiated cells were enriched in terms related to hematopoiesis regulation and differentiation (Benjamini q-value <10e -3 ) ( Fig. S2e and f) .
Examination of the chromatin state of the same cell subsets showed H3K4me3 and H3K36me3 densities correlated with expected transcript levels and cell type-specific signatures ( Fig. 1c , e-g, S2g and h). H3K4me3 densities at promoters of genes differentially expressed between different progenitor subsets, or between them and the later cell types, also showed expected relationships ( Fig. S3a) . In contrast, H3K27me3 occupancy was nearly identical across all 4 phenotypically defined CB progenitor subsets examined ( Fig. 1d and 1h; promoter Spearman R >0.97), and celltype specific signatures were apparent only in the mature cell types ( Fig. 1e and f) . Amongst the more mature populations, the lymphoid cells showed a significantly higher correlation of H3K27me3 density at promoters with progenitors as compared to the corresponding data for the erythroid precursors and the monocytes (Fig. 1d) . This was most readily evident true for the erythroid precursors whose RNA expression, H3K4me3 and H3K27me3 signatures at promoters showed the lowest correlation (average Spearman R < 0.56) with the results for the 4 progenitor populations (including MEPs) ( Fig. 1d) . There was no significant difference in H3K27me3 density within promoters of differentially expressed genes in a comparison of GMPs and MEPs (2-sided t-test, p >0.01, Fig. S3b) . In contrast, genes whose expression appeared down-regulated in monocytes and erythroid precursors compared to GMPs and MEPs, respectively, showed a significant gain of H3K27me3 density at the promoters of these down-regulated genes (2-sided ttest, p <2.2 x 10 -16 ). 
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Terminal differentiation is differentially associated with a genome-wide contraction of
H3K27me3 density in myeloid cells
We also identified different patterns of H3K27me3 occupancy in the 4 different mature cell types examined ( Fig. 1d and 1h) . Both monocytes and erythroid precursors showed significantly significantly fewer (30-52%) of H3K27me3-marked histones genome-wide ( Fig. S3c) with a pronounced contraction of the broad H3K27me3 domains shared by all 4 of the progenitor populations examined. The remaining H3K27me3 in the erythroid precursors and monocytes took on a more punctate structure reminiscent of that seen in pluripotent cell types ( Fig. 2a-e ).
Immunoprecipitated (IP) fragment distributions at promoters (± 2 Kb of transcription start sites (TSS)) were also significantly different in the monocyte and erythroid precursor populations by comparison to the 4 progenitor subsets or to both of the mature lymphoid cell types analyzed (B and T cells, kolmogorov-smirnov test, p<7x10 -12 ; Fig. 2c ). Examination of H3K27me3 promoter distributions in all of these cell phenotypes further revealed an increase in the proportion of H3K27me3-marked histones at promoters in the monocytes and erythroid precursors as compared to the progenitors from which they derive ( Fig. S3d and f) , without a measurable change in H3K4me3 promoter occupancy ( Fig. S3e and g) . To examine the functional consequence of the global alteration in H3K27me3 occupancy we measured H3K27me3 within gene bodies and related this expression difference across the cell types profiled ( Fig. 2f) . Consistent with genomewide patterns, we observed an increased number of genes with a loss in H3K27me3 density in monocytes and erythroid precursors (1418 and 1980, respectively) compared to mature lymphoid cells (B cells: 942 and T cells: 873) when compared to CD34 + CD38cells (Fig 2f) . Loss of H3K27me3 correlated with a greater proportion of up-regulated genes in monocytes and erythroid precursors compared to mature lymphoid cells (Figure 2g ). Among the genes which lost
H3K27me3 and were upregulated are well-known markers of erythroid and monocyte lineage differentiation including CD14, EPB42 and CD36 (Fig 2h-j) . Interestingly, in addition gene specific losses, we noted that H3K27me3 marked domains evident in all progenitor subsets are selectively absent in the differentiated monocytes and erythroid precursors in association with a loss of many large organized chromatin K27me3 domains (LOCKs) 20 (Fig. 3a-c) . In sharp contrast, these same LOCKs were generally retained in the B and T cells (Fig. 3a, d and e) . 
H3K27me3 LOCKs are enriched in lamina-associated domains (LADs)
To further characterize the LOCKs that are lost during the terminal differentiation of erythroid precursor cells and monocytes, we next examined the co-occurrence of other histone modifications and DNA methylation in these same regions. For this we applied ChromHMM 21 to generate an 18state model based on H3K4me1, H3K4me3, H3K27me3, H3K27ac, H3K36me3, H3K9me3 occupancy across all of the 8 different hematopoietic subsets examined (Fig. 4a) . Interestingly, H3K9me3 was found to be the most highly enriched mark within H3K27me3-defined LOCKS ( Fig. 4b and c) . Polycomb-repressed regions with or without H3K9me3 were found to be enriched in lamina associated domains (LADs) and in intergenic regions in both the progenitor subsets and in the B and T cells but, again, not in monocytes or erythroid precursors ( Fig. 4a, d, e and S4a).
In contrast, regions enriched in H3K9me3 alone were strongly associated with LADs in all cell types ( Fig. 4a and S4a). Monocytes and erythroid precursors showed reduced DNA methylation at LOCKs compared to the 4 progenitor subsets (2-sided t-test p<5.5 x 10 -8 ; Fig. 4f and S4b).
Erythroid precursors particularly, but also the monocytes showed reduced DNA methylation more broadly in chromatin states identified as polycomb-repressed and/or heterochromatin-repressed in the ChromHMM model ( Fig. S4c-f ). These findings are consistent with the previously reported reduced global level of DNA methylation of monocytes and neutrophils relative to different progenitor populations 12 . They also corroborate previous relationship between DNA methylation and H3K9me3 densities [22] [23] [24] and, in the present context, suggest that CD34 + hematopoietic progenitors share a higher order chromatin structure that is associated strongly with LADs and enriched in sites of H3K27me3 and H3K9me3. 
Hematopoietic progenitor subsets share lineage-specific enhancers marked by H3K27ac
We next sought to identify and compare the enhancer states of the 4 progenitor populations and the 4 more mature cell types examined. Accordingly, we identified the H3K27ac and H3K4me1 marked regions in each population and used the results to create a catalogue of active (H3K27ac and H3K4me1) and primed (H3K4me1) enhancers. Primed enhancers were relatively consistent across all 4 progenitor populations (Spearman, average R >0.8; Fig. 5a ) with active enhancers showing a higher degree of progenitor specificity (Spearman, average R >0.52; Fig. 5b and S5c) .
The progenitor populations also showed a consistently higher number of total enhancers, as measured by the sum of both the active and primed enhancer states, by comparison to the 4 more mature cell types (Fig. S5a) . In contrast, the number of active enhancers was higher in 3 of the 4 more mature cell types (2-sided t-test, p =0.026), the exception being the erythroid precursors that had a lower number of active enhancers compared with all other cell types (Fig. S5b) .
We next traced the gain or loss of H3K27ac and H3K4me1 from the most primitive CD34 + CD38cells to each differentiated cell type according to predicted trajectories. This exercise confirmed a directional loss of total enhancers during progenitor differentiation with the erythroid precursors showing the greatest overall loss of enhancers ( Fig. 5c) . However, the directional loss was largely restricted to primed enhancers with active enhancers staying either the same or increasing during differentiation ( Fig. 5c) . A majority of primed enhancers (>90%) and active enhancers (>72%)
found in mature cells were already evident in the progenitor populations (Fig. 5d, e and S5d) . A significant fraction (>80%) of the active enhancers in the differentiated cell types were also already primed across the progenitor subsets, as noted earlier for similar subsets of mouse hematopoietic cells 9 (Fig. S5e and f) . Interestingly, genes associated with enhancers found to be active in monocytes and erythroid precursors, but already active in progenitors also produced significantly higher levels of transcripts in the mature cells compared to their inferred parental progenitors (pairwise Wilcoxon signed-rank test Bonferroni corrected p <2x10 -5 , Fig. 5f ). They are also enriched in terms related to specific hematopoietic differentiation programs (Benjamini corrected p <10e -30 , Fig. S6a and b) . For example, SPI1 and EPB41 are associated with an active enhancer in progenitor and in lineage-restricted cells, with their expression increasing significantly during the full course of the differentiation process ( Fig. 5g and h) . Fig. S6c) . Relative to the CD34 + CD38population, MEPs and GMPs showed progression towards, and enrichment in, enhancers belonging to erythroid precursor and monocyte enhancer clusters, respectively (Fig. S6d) . GMPs in which cells with lymphoid potential appears largely eliminated 15, 16 .
Enrichment of differentiated enhancer clusters in
We next used the ROSE RANK algorithm 25 to identify the high amplitude active enhancers and clusters of H3K27ac (super-enhancers) in each of the 8 cell types analyzed. We observed a greater than 2-fold increase in the number of super-enhancers in the mature cell types compared to the numbers of these in the progenitor populations (Fig. 6a) . Surprisingly, we also found that a majority (>70%) of the active enhancers seen only in the mature cells were located within the boundaries of super enhancers, including the human counterparts of enhancers previously identified in differentiating mouse hematopoietic cells ( Fig. 6b and c) . Pathway analysis of genes associated with monocyte and erythroid precursor super-enhancers were enriched in terms related to leukocyte activity and erythroid differentiation, respectively ( Fig. S6e and f The broad H3K27me3 domains shared by CB progenitors that are no longer present in monocyte and erythroid precursors but persist in mature lymphoid cells (Fig. 3) led us to hypothesize that these differences may have functional roles in the processes that allow these different lineages to be produced. To test this possibility, we first compared the ability of 2 inhibitors that target complexes implicated in the maintenance of repressive chromatin; i.e., EPZ-6438, an inhibitor of EZH2, a major component of the polycomb repressive complex-2 (PRC2) and GSK-J4, a
H3K27me3 demethylase inhibitor to mimic the ability of ATRA to induce the granulopoietic differentiation potential of HL60 cells 26 . After 3 days of treatment with EPZ-6438, HL60 cells showed the same growth-arrest obtained by treatment with ATRA ( Fig. 7a and b) , no evidence in either of decreased viability which then appeared at a similar rate in both (Fig. 7b) . In contrast, treatment of HL60 cells with GSK-J4 exhibited no significant cell growth arrest or loss of viability for 9 days with results that were indistinguishable from the DMSO-treated controls. Interestingly, neither inhibitor when present together with ATRA produced any alteration to the response to ATRA alone at the concentrations tested. Thus, the inferred EPZ-6438-mediated H3K27me3 removal in HL60 cells appeared to drive the same phenotypic alterations as ATRA in HL60 cells, consistent with the importance of their removal to enable granulopoietic differentiation to proceed.
We then asked how these 2 inhibitors affect the granulopoietic and/or B-lymphopoietic differentiation potential of primary human hematopoietic progenitors maintained in vitro under conditions optimized to support the production of both of these lineages 16 . Accordingly, we initiated a series of cultures from a FACS-purified CD38 mid CD71 -CD10subset of CD34 + CB cells, that we have previously shown is highly enriched specifically in cells with one or both of these differentiation potentialities 16 . Assessment of the mature cell types present 3 weeks later showed a significant (2-sided t-test p<0.014) and selective decrease in cells expressing B cell markers in the exclusive presence of EPZ-6438, with no effects of either inhibitor on the output of cells expressing phenotypic markers of monocyte/macrophages or neutrophils ( Fig. 7c and   d) . These latter results suggest that continued repression of H3K27me3 sites by PRC2 complexes is required for progenitors with lymphoid potential to differentiate into mature lymphoid cells.
Together the effects of EPZ-6438 in both cell systems are consistent with a model in which the loss of H3K27me3 domains promotes the differentiation of mature myeloid cells from progenitors with that potential, whereas maintenance of H3K27m3 domains is required for the production of mature lymphoid cells.
Figure 7. EZH2 inhibition arrests HL60 cell growth and lymphoid production in vitro. A)
Total number of HL60 cells in culture treated with ATRA, GSK-J4 (K27me demethylase inhibitor) and EPZ (EZH2 inhibitor) every 3 days for 9 days. B) Percentage viability of HL60 cells in (A). Total cell number of CD19+ B cells, CD14+ monocytes, and CD15+ neutrophil cells after 3 weeks of culturing CB-derived CD45 high ;34 high ;38 mid ;71-;10-cells with lymphoid and non-lymphoid lineage-specific cytokines in presence or absence of EPZ (C) and GSK-J4 (D). * P <0.05, ** P <0.01 and *** P <0.001.
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Discussion
Epigenetic mechanisms play a central role in hematopoietic cell fate decisions [27] [28] [29] [30] [31] [32] . Of particular interest here is the repressive H3K27me3 chromatin modification that has been implicated in the regulation of hematopoiesis in vivo and in vitro [33] [34] [35] [36] [37] and how manipulation of H3K27me3 may impact the steps progenitors undergo to produce mature myeloid and lymphoid cell types 35, 38 . Both overexpression and inactivation of PRC2 components, responsible for the methylation of H3K27 have been reported in hematopoietic malignancies, further reinforcing the importance of H3K27me3 in regulating normal hematopoiesis 39, 40 . To further our understanding of the role of epigenetic states in these aspects of human hematopoiesis, we analyzed the epigenomic states of immunophenotypically defined, FACS-purified subpopulations of CD34 + and mature cells isolated from normal CB samples. Our analysis revealed a broad and stable repressive H3K27me3 landscape across all progenitor subsets analyzed; i.e., those defined phenotypically as CD34 + CD38 -, CMPs, GMPs and MEPs, which contrasted markedly with the dynamic and celltype specific landscape for active histone modifications. We also identified a striking and lineageselective genome-wide H3K27me3 signature evident in 2 mature myeloid cell types (monocytes and erythroid precursors) and not seen in 2 mature lymphoid cell types (B cells and T cells).
Intriguingly, the H3K27me3 signature common to the monocytes and erythroid precursors displayed a punctuated structure reminiscent of the H3K27me3 signature associated with embryonic stem cells (ESCs) 41 .
In the classical Waddington 42 view, the chromatin of very primitive cells is envisaged to exist in a privileged state allowing for the dynamic remodeling required for lineage restriction and later activation of a differentiation program. One early finding in support of such privileged chromatin in ESCs is their bivalent state 41, [43] [44] [45] in which the nucleosomes in the promoters of developmentally important genes are marked by both permissive and repressive histone modifications (H3K4me3 and H3K27me3, respectively) that subsequently resolve to an homogenously active or repressed chromatin state as differentiation occurs 41, 43 . However, subsequent epigenomic studies across a broad range of primary tissues have revealed that bivalent promoters are not unique to ESC chromatin and can be found in many cell types including fully functional, terminally differentiated cell types 3, 18 . Another prevailing model of H3K27me3 occupancy during ESC differentiation posits that, upon differentiation, H3K27me3 genomic occupancy spreads outwards from discrete focal regions to occupy large genomic regions 45 , an observation which has correlated with the differentiation capacity of these cells.
Here, we demonstrate that H3K27me3 reverts back to a punctuated structure in cells that have differentiated into certain types of mature blood cells. This unexpected observation suggests that at some point in the differentiation of these cells there is an overall loss of repressive chromatin rather than a further compaction as might have been predicted from studies of ESC differentiation 45 . Why B and T cells retain a broader H3K27me3 landscape also raises interesting questions. One possibility is that this could be related to their known ability to activate a "stem-like" state upon antigenic stimulation and then execute a large expansion of their progeny 46 .
We also found that this surprising H3K27me3 contraction evident in erythroid precursors and monocytes includes a specific loss of H3K27me3 marked LOCKs that in the progenitors and mature lymphoid cells show co-occupancy with another suppressive histone modification,
H3K9me3. The lineage-specific restructuring of H3K27me3 specifically during myeloid differentiation highlights the importance of higher order chromatin structure in differentiation and establishment of cellular identity in the hematopoietic system. H3K27me3 and H3K27me3/K9me3 enriched regions common to progenitor and lymphoid cells and lost in different mature myeloid cell types are also strongly enriched in LADs, thus reinforcing the concept that myeloid cells can also be distinguished from lymphoid and progenitors based on lamin distribution and nucleus rigidity 47 . Taken together these observations provide molecular support of the observation that manipulation of lamin expression specifically modulates myeloid cell differentiation 47 .
In contrast to H3K27me3, we found the active enhancer mark H3K27ac is dynamic across all progenitor populations analyzed and the majority of active enhancers identified in the mature cells were first detected in their traditionally defined progenitor populations despite recent evidence of the considerable heterogeneity in differentiation potential and other molecular features they display 16 . Key lineage-specific regulators were identified among the genes associated with active enhancers in the progenitor populations. During differentiation, these active enhancers increase in width and amplitude and expression of associated genes increases. Our results thus suggest that priming of key regulatory regions during hematopoietic differentiation occurs in the context of traditionally described active enhancers whose activity is reinforced and increases during lineage restriction. This finding refines the currently proposed primed (H3K4me1) to an active enhancer model 9 and suggests that additional features beyond the presence of H3K27ac, for example formation of lineage specific phase separated condensates 48 , may be required for full enhancer activity.
The appearance of lineage-specific active enhancers in myeloid progenitor cells prior to the acquisition by their mature progeny of a global H3K27me3 contraction is particularly intriguing.
This finding suggests that active enhancers already present in progenitor cells are constrained by BD Bioscience, ON, Canada), and anti-CD235 eFluor 450 (clone 6A7M eBioscience). Isolated cells were then centrifuged (500rcf, 6min) and had their supernatant removed prior to rapid freezing using dry ice or liquid nitrogen then stored at -80°C.
Isolation of human CB populations
RNA-seq
Total RNA was rRNA depleted using NEBNext rRNA Depletion Kit (New England BioLabs, E6310L 
Low Input Native ChIP-seq
ChIP-seq was performed as previously described 17 Sequence reads with BWA mapping quality scores <5 are discarded and reads that aligned to the same genomic coordinate were counted only once in the profile generation. A standardized analytical pipeline developed by the International Human Epigenomic Consortium (IHEC) (http://ihec-epigenomes.org/) was applied to qualify the resulting data.
ChIP-seq Analysis
Genome browser tracks were generated by converting bam files to wiggle files using a custom script (http://www.epigenomes.ca/tools-and-software ). Wiggle files then converted to bigwig for display on UCSC genome browser by UCSC tool, wig2Bigwig script. MACS2 54 was employed to identify enriched regions with a false discovery rate (FDR) value of ≤ 0.01 for H3K4me3, H3K4me1 and H3K27ac peaks in ChIP-seq data. Finder2.0 (http://www.epigenomes.ca/tools-andsoftware/finder ) was used to identify enriched regions for H3K27me3 and H3K9me3 ChIP-seq data. Enriched regions overlapping with ENCODE blacklist regions were eliminated. ChIP-seq signal was calculated as tag density generated using HOMER v4.10 55 and normalized to total number of tags within enriched regions. Heat map of fragment distribution at promoters were generated by deeptools 56 . All other figures were generated by R statistical software 52 .
ChromHMM 57 was used to identify 18 chromatin states based on MACS2 54 identified enriched regions in each cell type as previously described 21 . To identify active enhancers, we first found annotations. We then selected for genes with >=20% of their genome covered with H3K27me3.
Whole Genome Bisulfite Sequencing
Whole genome bisulfite libraries were constructed as previously described 61 minutes. The Bisulfite converted single stranded DNA was converted to double stranded DNA through 1 cycle of PCR with random hexamer as previously described 61 followed by standard illumine library construction. Libraries were aligned using Novoalign V3.02.10 (www.novocraft.com) to human genome assembly GRCh37 (hg19). Duplicate reads were marke by Picard V1.31 (http://picard.sourceforge.net). and discarded (http://picard.sourceforge.net).
